A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine

NCT03450915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12460

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: M-001
BIOLOGICAL: Saline

Sponsor

BiondVax Pharmaceuticals ltd.